Engagement of the α2β1 integrin by stromal VCAM1 and activation of CXCR4 together promote survival signaling via the Syk tyrosine kinase in chronic lymphocytic leukemia (CLL). This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.